• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » Sue Coons

Sue Coons

Articles

ARTICLES

scientist

Adaptive Trials Show ‘Fast Science’ Can Be Good Science

October 4, 2022
Sue Coons and James Miessler
In the push to accelerate research by shortening clinical trials’ duration, sponsors and sites need to be aware of the risks “fast science” can introduce and focus on trial designs that are proven to maintain scientific integrity while speeding results. Read More
Time - COVID

Fast Science: How to Speed Clinical Research Without Cutting Corners

September 30, 2022
Sue Coons
For years, the drug development process has been slow and steady — sometimes painfully so — with a mean timeline of 10 years between a drug’s clinical testing and its approval. Then the COVID-19 pandemic hit and Pfizer received an emergency use authorization for the vaccine less than a year after the virus was identified. Read More
Inclusion text

Improving Minority Inclusion in Clinical Trials: Rethinking ‘Race’ and Other Variables to Improve Diversity

September 30, 2021
Sue Coons
The clinical research industry has made some progress toward improving diversity in clinical research, but the latest U.S. Census still shows minorities are underrepresented in trials. Read More

Research misconduct on the radar for decades

September 30, 2020
Sue Coons
Most of the general public first heard about research misconduct from hearings on the problem held by then-Rep. Albert Gore Jr. (D-Tenn.), chairman of the Investigations and Oversight Subcommittee of the House Science and Technology Committee, in 1981 Read More
Investgation - pills

Understand, prevent and mitigate clinical trial misconduct and fraud

September 30, 2020
Sue Coons
Research misconduct and fraud not only ruin reputations of investigators and institutions but can also damage the public’s trust in clinical research. Consider the case of Piero Anversa, a key figure in stem cell research. Anversa was accused of falsifying or fabricating data in more than 30 research papers. Read More
Clinical staff with medical mask

Planning for and supporting staff needs in a crisis

July 31, 2020
Sue Coons
Having the right resources at the right time is critical to a clinical trial’s success, and no resource is more valuable than a site’s staff. But the uncertainty about future needs caused by the current pandemic makes it difficult to plan for the right staff mix and scheduling. Read More

Follow the “Golden Rule” When Creating a Trial Billing Plan

April 29, 2019
Sue Coons
When preparing a billing plan for a clinical trial, follow the Medicare model to make the best case for reimbursement from other payers, a clinical research compliance expert advises. Read More

Paying for Trial Participation: A Question of Incentive v. Influence

April 22, 2019
Sue Coons
When it comes to offering to pay clinical trial subjects to participate, the line between compensation and coercion is difficult to draw but all too easy to cross. Read More

Upcoming Events

  • 06Jun

    Gene & Cell Therapy Regulation: Comparability and Other New Developments

  • 07Jun

    Developing World-Class SOPs: Optimizing Quality and Compliance

  • 08Jun

    Implementing ICH E8 R1 Recommendations Increases Site and Participant Relationship Scoring Measures

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing